Viewing Study NCT02684357


Ignite Creation Date: 2025-12-24 @ 6:50 PM
Ignite Modification Date: 2026-01-24 @ 5:47 PM
Study NCT ID: NCT02684357
Status: COMPLETED
Last Update Posted: 2021-08-23
First Post: 2016-02-16
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: BI 655066 Versus Placebo & Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis
Sponsor: AbbVie
Organization: